Q0249 Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
Short descriptor: Tocilizumab for covid-19
Look up Q0249 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
Q0249 is the HCPCS Level II code for Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Vaccinations.
Classification & CMS Attributes
- Section
- Q: Temporary Codes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Vaccinations (indicator 54)
- Type of Service
- Pneumococcal/flu/hepatitis B vaccine
- Effective Date
- 2021-06-24
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference Q0249 with the canonical source and edition:
Q0249 — Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q0249
Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q0249